Immune Checkpoint Inhibitor-Associated Myositis: Expanding the Spectrum of Cardiac Complications of the Immunotherapy Revolution

Circulation. 2018 Aug 14;138(7):743-745. doi: 10.1161/CIRCULATIONAHA.118.035898.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Adverse Drug Reaction Reporting Systems
  • Aged
  • Aged, 80 and over
  • Antineoplastic Agents, Immunological / adverse effects*
  • Databases, Factual
  • Female
  • Humans
  • Immunotherapy / adverse effects*
  • Immunotherapy / methods
  • Male
  • Middle Aged
  • Myositis / chemically induced*
  • Myositis / diagnosis
  • Myositis / immunology
  • Myositis / mortality
  • Pharmacovigilance
  • Prognosis
  • Risk Assessment
  • Risk Factors
  • Time Factors

Substances

  • Antineoplastic Agents, Immunological